Abstract
The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of gastric cancer specifically as it relates to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chicago Consensus Working Group. The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08318-8.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Methodology. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08317-9.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08325-9.
Chicago Consensus Working Group.The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08316-w.
Chicago Consensus Working Group.The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08315-x.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08324-w.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08322-y.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08321-z.
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumor. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08319-7.
Chicago Consensus Working Group. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08323-x.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Hu YF, Deng ZW, Liu H, et al. Staging laparoscopy improves treatment decision-making for advanced gastric cancer. World J Gastroenterol. 2016;22(5):1859–1868.
Muntean V, Mihailov A, Iancu C, et al. Staging laparoscopy in gastric cancer: accuracy and impact on therapy. J Gastrointestin Liver Dis. 2009;18(2):189–195.
Fujimura T, Kinami S, Ninomiya I, et al. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer. Endoscopy. 2002;35:569–574.
Bernards N, Creemers GJ, Nieuwenhuijzen GA, Bosscha K, Pruijt JF, Lemmens VE. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol. 2013;24(12):3056–3060.
Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–1581.
Strong VE, Song KY, Park CH, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg. 2010;251(4):640–646.
Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89(11):2237–2246.
Bonnot PE, Piessen G, Kepenekian V, et al; FREGAT and BIG-RENAPE Networks. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028–2040.
Glehen O, Gilly FN, Arvieux C, et al; Association Française de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370–2377.
Coccolini F, Catena F, Glehen O, et al. Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis. Eur J Surg Oncol. 2015;41(7):911–919.
Yonemura Y, Elnemr A, Endou Y, et al. Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection. Gastroenterol Res Pract. 2012;2012:521487.
Königsrainer I, Horvath P, Struller F, Königsrainer A, Beckert S. Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases. J Gastric Cancer. 2014;14(2):117–122.
Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg. 2005;92(3):370–375.
Fujitani K, Yang H-K, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309–318.
Bang YJ, Van Cutsem E, Feyereislova A, et al; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–697.
Shirao K, Boku N, Yamada Y, et al; Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group. Randomized phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106). Jpn J Clin Oncol. 2013;43(10):972–980.
Yonemura Y, Canbay E, Yoshio E, et al. Comprehensive treatment for the peritoneal metastasis from gastric cancer. World J Surg Proc. 2015;5(2):187–197.
Badgwell B, Blum M, Das P, et al. Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma. Ann Surg Oncol. 2017;24(11):3338–3344.
Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg. 2003;138(1):26–33.
Yonemura Y, Bandou E, Kinoshita K, et al. Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am. 2003;12(3):635–648.
Acknowledgments
Collaborators: Francisco J. Izquierdo, MD, Clínica Santa María, Department of Surgery, Providencia, Chile. Darryl Schuitevoerder, MBBS, University of Chicago, Department of Surgery, Chicago, IL. Alejandro Plana, BA, University of Chicago, Department of Surgery, Chicago, IL. Oliver S. Eng, MD, University of Chicago, Department of Surgery, Chicago, IL. Scott K. Sherman, MD, University of Chicago, Department of Surgery, Chicago, IL. Brian Badgwell, MD, MS, MD Anderson Cancer Center, Surgical Oncology, Houston, TX. Fabian M. Johnston, MD, MHS, Johns Hopkins University, Surgery, Baltimore, MD. Sherif Abdel-Misih, MD, Stony Brook University, Surgery, Stony Brook, NY. Dan G. Blazer III, MD, Duke University, Surgery, Durham, NC. Sean P. Dineen, MD, Moffitt Cancer Center, Gastrointestinal Oncology, Tampa, FL. Ana Luiza Gleisner, MD, PhD, University of Colorado, Surgery, Aurora, CO. Travis E. Grotz, MD, Mayo Clinic, Department of Surgery, Rochester, MN. Nader Hanna, MD, University of Maryland School of Medicine, Surgery, Baltimore, MD. Harveshp Mogal, MD, MS, Medical College of Wisconsin, Surgery, Milwaukee, WI. Mecker G. Möller, MD, University of Miami Miller School of Medicine, Department of Surgery, Division of Surgical Oncology, Miami, FL. Sanjay S. Reddy, MD, Fox Chase Cancer Center, Department of Surgery, Philadelphia, PA. Maheswari Senthil, MD, Loma Linda University Health, Surgical Oncology, Loma Linda, CA. Joshua H. Winer, MD, Emory University, Division of Surgical Oncology, Atlanta, GA. Daniel E. Abbott, MD, University of Wisconsin, Department of Surgery, Madison, WI. Steven A. Ahrendt, MD, University of Colorado, Department of Surgery, Aurora, CO. Mazin Al-kasspooles, MD, University of Kansas Medical Center, Department of Surgery, Division of Surgical Oncology, Kansas City, KS. Lindsay Alpert, MD, University of Chicago, Department of Pathology, Chicago, IL. Farin Amersi, MD, Cedars-Sinai Medical Center, Los Angeles, CA. Amanda K. Arrington, MD, University of Arizona, Surgery, Tucson, AZ. Robert M. Barone, MD, MS, Sharp HealthCare, University of San Diego School of Medicine, Division Surgical Oncology, Surgery, La Jolla, CA. Joel M. Baumgartner, MD, MAS, University of California San Diego, Surgery, La Jolla, CA. Richard N. Berri, MD, Ascension St. John Hospital, Surgical Oncology, Grosse Pointe Woods, MI. Lana Bijelic, MD, Inova Schar Cancer Institute, Surgical Oncology, Fairfax, VA. Wilbur B. Bowne, MD, Drexel University College of Medicine, Surgery, Philadelphia, PA. Charles Komen Brown, MD, PhD, AMITA Health, Surgery, La Grange, IL. Daniel V. Catenacci, MD, University of Chicago, Medicine, Chicago, IL. Carlos H.F. Chan, MD, PhD, University of Iowa Hospitals & Clinics, Department of Surgery, Iowa City, IA. Clifford S. Cho, MD, University of Michigan Medical School, Department of Surgery, Ann Arbor, MI. M. Haroon A. Choudry, MD, University of Pittsburgh, Surgery, Surgical Oncology, Pittsburgh, PA. Callisia N. Clarke, MD, MS, Medical College of Wisconsin, Surgery, Milwaukee, WI. Jordan M Cloyd, MD, The Ohio State University, Department of Surgery, Columbus, OH. James C. Cusack Jr, MD, Massachusetts General Hospital, Department of Surgery, Boston, MA. Abraham H. Dachman, MD, University of Chicago Medicine, Radiology, Chicago, IL. Jeremiah L. Deneve, DO, University of Tennessee Health Science Center, Surgery, Memphis, TN. Leopoldo J. Fernandez, MD, Virginia Commonwealth University Massey Cancer Center, Hunter Holmes McGuire VA Medical Center, Surgical Oncology, Richmond, VA. James Fleshman, MD, Baylor University Medical Center, Department of Surgery, Dallas TX. T. Clark Gamblin, MD, MS, MBA, Medical College of Wisconsin, Department of Surgery, Milwaukee, WI. Alexandra Gangi, MD, Cedars-Sinai Medical Center, Surgical Oncology, Department of Surgery, Los Angeles, CA. Georgios V. Georgakis, MD, PhD, Stony Brook University, Department of Surgery, Division of Surgical Oncology, Stony Brook, NY. Erin W. Gilbert, MD, Oregon Health & Science University, Department of Surgery, Portland, OR. Martin D. Goodman, MD, Tufts Medical Center, Surgical Oncology, Boston, MA. Anand Govindarajan, MD, MSc, Sinai Health System, University of Toronto, Division of General Surgery, Toronto, ON, Canada. Vadim Gushchin, MD, Institute for Cancer Care at Mercy, Surgical Oncology, Baltimore, MD. Carla Harmath, MD, University of Chicago, Radiology, Chicago, IL. Andrea Hayes-Jordan, MD, University of North Carolina School of Medicine, Department of Surgery, Division of Pediatric Surgery, Chapel Hill, NC. Aliya N. Husain, MD, University of Chicago, Pathology, Chicago, IL. Kamran Idrees, MD, MSCI, MMHC, Vanderbilt University Medical Center, Department of Surgery, Nashville, TN. Chukwuemeka Ihemelandu, MD, MedStar Georgetown University Medical Center, Surgical Oncology, Washington, DC. Hae** In, MD, MBA, MPH, Montefiore Medical Center, Surgery, Bronx, NY. David Jiang, MD, University of Chicago, Department of Surgery, Chicago, IL. John M. Kane III, MD, Roswell Park Comprehensive Cancer Center, Surgical Oncology, Buffalo, NY. Giorgos Karakousis, MD, Hospital of the University of Pennsylvania, Surgery, Philadelphia, PA. Kaitlyn J. Kelly, MD, University of California San Diego, Surgery, La Jolla, CA. Timothy J. Kennedy, MD, MBA, Rutgers Cancer Institute of New Jersey, GI Surgical Oncology, New Brunswick, NJ. Xavier M. Keutgen, MD, University of Chicago, Surgery, Division of Surgical Oncology, Endocrine Surgery Research Program, Chicago, IL. Hedy Lee Kindler, MD, University of Chicago, Section of Hematology/Oncology, Chicago, IL. Michael D. Kluger, MD, MPH, Columbia University College of Physicians and Surgeons, Division of GI & Endocrine Surgery, New York, NY. Byrne Lee, MD, City of Hope, Division of Surgical Oncology, Duarte, CA. Lloyd A. Mack, MD, MSc, University of Calgary, Departments of Surgery and Oncology, Calgary, AB, Canada. Ugwuji N. Maduekwe, MD, MMSc, University of North Carolina at Chapel Hill, Department of Surgery, Division of Surgical Oncology and Endocrine Surgery, Chapel Hill, NC. Grace Z. Mak, MD, University of Chicago, Department of Surgery, Section of Pediatric Surgery, Chicago, IL. Joshua M.V. Mammen, MD, PhD, University of Kansas, Department of Surgery, Kansas City, KS. Melvy Sarah Mathew, MD, University of Chicago, Department of Radiology, Chicago, IL. Marcovalerio Melis, MD, NYU School of Medicine, Surgery, New York, NY. Nelya Melnitchouk, MD, MSc, Brigham and Women’s Hospital, Harvard Medical School, Department of Surgery, Boston, MA. Ryan P. Merkow, MD, MS, Northwestern University, Feinberg School of Medicine, Department of Surgery, Evanston, IL. Aytekin Oto, MD, MBA, University of Chicago, Radiology, Chicago, IL. Colette R. Pameijer, MD, Penn State College of Medicine, Department of Surgery, Hershey, PA. Patricio M. Polanco, MD, University of Texas Southwestern Medical Center, Department of Surgery, Division of Surgical Oncology, Dallas, TX. Sam G. Pappas, MD, Rush University Medical Center, Surgery, Chicago, IL. Blase N. Polite, MD, MPP, University of Chicago, Department of Medicine, Chicago, IL. Richard Royal, MD, MD Anderson Cancer Center, Surgical Oncology. George Salti, MD, Edward-Elmhurst Health and University of Illinois at Chicago, Surgical Oncology, Chicago, IL. Armando Sardi, MD, Mercy Medical Center, Surgical Oncology, Baltimore, MD. Namrata Setia, MD, University of Chicago, Department of Pathology, Chicago, IL. Lucas Sideris, MD, FRCSC, University of Montreal, Surgery, Montreal, QC, Canada. Joseph Skitzki, MD, Roswell Park Comprehensive Cancer Center, Department of Surgical Oncology, Buffalo, NY. Jula Veerapong, MD, University of California San Diego, Surgical Oncology, La Jolla, CA. Konstantinos I. Votanopoulos, MD PhD, Wake Forest, Surgery, Winston-Salem, NC. Michael G. White, MD, MSc, University of Chicago, Department of Surgery, Chicago, IL. Shu-Yuan **ao, MD, University of Chicago, Chicago, IL, and Wuhan University Zhongnan Hospital, Department of Pathology, Wuhan, China. Rhonda K. Yantiss, MD, Weill Cornell Medicine, Pathology and Laboratory Medicine, New York, NY. Nita Ahuja, MD, MBA, Yale University, Surgery, New Haven, CT. Andrew M. Lowy, MD, UC San Diego Health, Department of Surgery, La Jolla, CA. Paul H. Sugarbaker, MD, MedStar Washington Hospital Center, Washington, DC. Charles Staley, MD, Emory University School of Medicine, Department of Surgery, Atlanta, GA. Daniel M Labow, MD, Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, NY. Jason M. Foster, MD, University of Nebraska/Nebraska Medicine, Surgery, Division of Surgical Oncology, Omaha, NE. Jesus Esquivel, MD, Frederick Memorial Hospital, Surgical Oncology, Frederick, MD. H. Richard Alexander Jr, MD, Rutgers Cancer Institute of New Jersey, Division of Surgical Oncology, New Brunswick, NJ. Edward A. Levine, MD, Wake Forest University, Surgical Oncology, Winston-Salem, NC. Laura A. Lambert, MD, Huntsman Cancer Institute/University of Utah, General Surgery, Salt Lake City, UT. David L. Bartlett, MD, University of Pittsburgh, Surgery, Pittsburgh, PA. Kiran Turaga, MD, MPH, University of Chicago, Department of Surgery, Chicago, IL.
Funding
The Irving Harris Foundation and the University of Chicago
Author information
Authors and Affiliations
Consortia
Ethics declarations
Disclosures
James C. Cusack reports grants from Lumicell Inc. outside the submitted work. Carla Harmath serves on the medical advisory council of Accumen. Hedy Kindler reports personal fees and non-financial support from Inventiva, AstraZeneca, Boehringer Ingelheim, Merck, and Paredox; personal fees from Aldeyra Therapeutics, Bayer, BMS, Erytech, Five Prime Therapeutics, Ipsen Pharmaceuticals, Kyowa, and MedImmune; and funds to support clinical trials at her institution from Aduro, AstraZeneca, Bayer, BMS, Deciphera, GSK, Lilly, Merck, MedImmune, Polaris, Verastem, and Blueprint, all outside the submitted work. Aytekin Oto reports grants from Philips Healthcare, Guerbet, and Profound Healthcare, and serves as a medical advisory board member for Profound Healthcare, all outside the submitted work. Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. Jesus Esquivel reports personal fees from Eight Medical. The remaining authors disclosed no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The collaborators for the Chicago Consensus Working Group are listed in the acknowledgments.
Correspondence to: K. Turaga, MD
Department of Surgery, University of Chicago, Chicago, IL
e-mail: kturaga@surgery.bsd.uchicago.edu
Rights and permissions
About this article
Cite this article
Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Ann Surg Oncol 27, 1768–1773 (2020). https://doi.org/10.1245/s10434-020-08320-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08320-0